Four BGI Group subsidiaries urged an appellate court on Wednesday to overturn findings that they infringed valid patents for rapid DNA sequencing held by Illumina Cambridge Ltd., saying the inventions were obvious considering the prior research in the field.
Four BGI Group subsidiaries urged an appellate court on Wednesday to overturn findings that they infringed valid patents for rapid DNA sequencing held by Illumina Cambridge Ltd., saying the inventions were obvious considering the prior research in the field.
A California federal jury heard testimony Friday from gene sequencing company Illumina's expert witness that 10 judges who previously upheld Illumina's patents behind its next-generation technology "got it right," one day after Chinese-owned DNA sequencing company Complete Genomics offered expert testimony that Illumina's patents are invalid as obvious.